Related Experiment Video

Updated: Dec 31, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.7K

MT1JP inhibits glioma progression via negative regulation of miR-24

Jinming Chen1, Jianyun Lou1, Shaochun Yang1

  • 1Department of Neurosurgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China.

Oncology Letters
|January 1, 2020
PubMed

Insights

Metallothionein 1J (MT1JP) is downregulated in glioma, inhibiting cancer progression and invasion. MT1JP suppresses glioma by negatively regulating microRNA-24 (miR-24), offering potential as a diagnostic biomarker and therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Long noncoding RNAs (lncRNAs) are implicated in human cancers, including glioma.
  • Metallothionein 1J (MT1JP) is known to regulate gastric cancer but its role in glioma is unclear.

Purpose of the Study:

  • To investigate the biological role and mechanism of MT1JP in glioma.
  • To determine if MT1JP can serve as a diagnostic biomarker or therapeutic target for glioma.

Main Methods:

  • Analysis of MT1JP expression in glioma tissues and cell lines.
  • Overexpression studies to assess MT1JP's effect on glioma cell proliferation and invasion.
  • Investigation of the interaction between MT1JP and microRNA-24 (miR-24).
  • Rescue experiments to confirm the mechanism of MT1JP's tumor suppressive function.

Main Results:

  • MT1JP expression was significantly downregulated in glioma tissues and cell lines.
  • Lower MT1JP levels correlated with glioma progression and poorer patient survival.
  • MT1JP overexpression inhibited glioma cell proliferation and invasion.
  • MT1JP negatively regulated miR-24 expression, and this interaction mediated MT1JP's tumor suppressive effects.

Conclusions:

  • MT1JP acts as a tumor suppressor in glioma by inhibiting progression and invasion.
  • MT1JP exerts its function through the negative regulation of miR-24.
  • MT1JP shows potential as a novel diagnostic biomarker and therapeutic target for glioma.
Keywords:
gliomainvasionmetallothionein 1JmicroRNA-24proliferationpseudogene

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

5.9K
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

3.1K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K